The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
Hadeel ObiedatNasr N AlrabadiEyad SultanMarwa Al ShattiMalek ZihlifPublished in: BMC medical genetics (2018)
Our results suggested that ERCC1 8092 C allele may play a role as a candidate prognostic marker in patients with osteosarcoma.